Dow Down 0.14% Nasdaq Up 0.13%

Actavis plc (ACT)

-NYSE
226.60 Up 0.35(0.15%) 11:41AM EDT - Nasdaq Real Time Price
Prev Close:226.25
Open:226.64
Bid:225.88 x 100
Ask:226.01 x 200
1y Target Est:264.20
Beta:0.32
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:224.80 - 227.44
52wk Range:130.06 - 230.77
Volume:388,960
Avg Vol (3m):2,420,110
Market Cap:59.88B
P/E (ttm):N/A
EPS (ttm):-3.60
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACTUp 0.15%59.88B
MYLUp 1.17%18.07B
NVSDown 0.03%215.74B
TEVADown 0.21%45.67B

Key Statistics

Forward P/E (1 yr):13.79
P/S (ttm):5.91
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :13.28
Quarterly EPS Est (Sep-14) :3.10
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):0.86

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Actavis plc, an integrated specialty pharmaceutical company, is engaged in the development, manufacture, marketing, sale, and distribution of pharmaceutical products in the Americas, Europe, the Middle East, Africa, Australia, and the Asia Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback